1887

Abstract

BALF2, which encodes the major DNA-binding protein of Epstein–Barr virus (EBV), is expressed during the early stage of the lytic cycle. The location of the BALF2 promoter was identified by primer extension, which indicated that the transcription start is located at nucleotide 164,782 of the EBV genome. Transfection analyses revealed that, similar to other EBV early promoters, the BALF2 promoter is activated by the EBV-encoded transcription factors Rta and Zta. The promoter is also synergistically activated if both transcription factors are present in B lymphocytes and in epithelial cells. Deletion analysis and electrophoretic mobility-shift assay revealed that the region between nucleotides −134 and −64 contains Zta- response elements and the region between nucleotides −287 and −254 contains Rta-response elements. This study demonstrates the importance of Rta and Zta in regulating the transcription of EBV early genes.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-10-2747
1999-10-01
2020-10-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/10/0802747a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-10-2747&mimeType=html&fmt=ahah

References

  1. Chang Y. N., Dong D. L., Hayward G. S., Hayward S. D.. 1990; The Epstein–Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. Journal of Virology64:3358–3369
    [Google Scholar]
  2. Chang P.-J., Chang Y.-S., Liu S.-T.. 1998a; Characterization of the BcLF1 promoter in Epstein–Barr virus. Journal of General Virology79:2003–2006
    [Google Scholar]
  3. Chang P. J., Chang Y. S., Liu S. T.. 1998b; Role of Rta in the translation of bicistronic BZLF1 of Epstein–Barr virus. Journal of Virology72:5128–5136
    [Google Scholar]
  4. Chavrier P., Gruffat H., Chevallier-Greco A., Buisson M., Sergeant A.. 1989; The Epstein–Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities. Journal of Virology63:607–614
    [Google Scholar]
  5. Chevallier-Greco A., Gruffat H., Manet E., Calender A., Sergeant A.. 1989; The Epstein–Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R. Journal of Virology63:615–623
    [Google Scholar]
  6. Cox M. A., Leahy J., Hardwick J. M.. 1990; An enhancer within the divergent promoter of Epstein–Barr virus responds synergistically to the R and Z transactivators. Journal of Virology64:313–321
    [Google Scholar]
  7. Decaussin G., Leclerc V., Ooka T.. 1995; The lytic cycle of Epstein–Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame. Journal of Virology69:7309–7314
    [Google Scholar]
  8. de Wet J. R., Wood K. V., DeLuca M., Helinski D. R., Subramani S.. 1987; Firefly luciferase gene: structure and expression in mammalian cells. Molecular and Cellular Biology7:725–737
    [Google Scholar]
  9. Fixman E. D., Hayward G. S., Hayward S. D.. 1992; Trans-acting requirements for replication of Epstein–Barr virus ori-Lyt. Journal of Virology66:5030–5039
    [Google Scholar]
  10. Furnari F. B., Adams M. D., Pagano J. S.. 1992; Regulation of the Epstein–Barr virus DNA polymerase gene. Journal of Virology66:2837–2845
    [Google Scholar]
  11. Gruffat H., Sergeant A.. 1994; Characterization of the DNA- binding site repertoire for the Epstein–Barr virus transcription factor R. Nucleic Acids Research22:1172–1178
    [Google Scholar]
  12. Holley-Guthrie E. A., Quinlivan E. B., Mar E. C., Kenney S.. 1990; The Epstein–Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner. Journal of Virology64:3753–3759
    [Google Scholar]
  13. Luka J., Kallin B., Klein G.. 1979; Induction of the Epstein–Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology94:228–231
    [Google Scholar]
  14. Nonoyama M., Pagano J. S.. 1972; Replication of viral deoxyribonucleic acid and breakdown of cellular deoxyribonucleic acid in Epstein–Barr virus infection. Journal of Virology9:714–716
    [Google Scholar]
  15. Polack A., Delius H., Zimber U., Bornkamm G. W.. 1984; Two deletions in the Epstein–Barr virus genome of the Burkitt lymphoma nonproducer line Raji. Virology133:146–157
    [Google Scholar]
  16. Takada K., Zur Hausen H.. 1984; Induction of Epstein–Barr virus antigens by tumor promoters for epidermal and nonepidermal tissues. International Journal of Cancer33:491–496
    [Google Scholar]
  17. Tsurumi T., Kobayashi A., Tamai K., Yamada H., Daikoku T., Yamashita Y., Nishiyama Y.. 1996; Epstein–Barr virus single- stranded DNA-binding protein: purification, characterization, and action on DNA synthesis by the viral DNA polymerase. Virology222:352–364
    [Google Scholar]
  18. zur Hausen H., Fresen K. O., Bornkamm G. W.. 1978; Epstein–Barr virus genomes and their biological functions: a review. IARC Scientific Publications24:3–10
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-10-2747
Loading
/content/journal/jgv/10.1099/0022-1317-80-10-2747
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error